Exhibit 10.2
AMENDMENT
METASYN INC.("METASYN") and SUMITOMO CORPORATION ("SUMITOMO") hereby agree that
the parties shall amend the Article 8.2 of the AGENCY AGREEMENT dated on 13th of
March, 1992 (the "Original Agreement") as follows:
l. Amendment
Article 8 of the Original Agreement is amended by modifying paragraph 2
to read as follows :
Notwithstanding the provisions of the preceeding article 8.1, in
case by the end of March, 1994 Company enters into Arrangements
for blood pool MRI agent with any Partner pursuant to which
Companv would be entitled to receive more than [ ]* within one
(l) year from the date of conclusion of an agreement for such
Arrangements, Company shall pay a commission of [ ]* of [ ]* and
[ ]* and [ ]* of [ ]* received by Company under such
Arrangements.
2. Effect of Amendment
The amendments to the Orinial Agreement hereby made shall become
effective from June 26, 1992 ,and be applied to all transactions made
or to be made on or after such date. Except as specificaily provided
herein, the Original Agreement, as amended hereby, remains in full
force and effect, and each refernce to "hereby","hereof" and words of
similar import shall refer to the Original Agreement as amended hereby.
3. Definitions
All terms used herein, except as defined herein, shall have the
meanings ascribed in the Original Agreement.
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed
by their duly authorized representatives as of the day and year first above
written.
METASYN INC. SUMITOMO CORPORATION
BY:/s/ Xxxxxxx X. Xxxxxxx By/s/ X. Xxxxxxxxx
------------------------- ------------------------------
Name: Xxxxxxx X. Xxxxxxx Name: X.Xxxxxxxxx
Title: Chairman and CEO Title: Assistant to
General Manager
New Drug & Biochem.
Development Dept.
Date: June 26, 1992 Date: June 23
*Confidential information omitted and filed with the Commission